US2013045227A1PendingUtilityA1
Uses of red yeast rice in treating dengue virus infection
Est. expiryApr 8, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61P 31/12A61K 36/062A61K 9/48A61K 36/899A61P 31/14Y02A50/30
25
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides a method of using red yeast rice fermented product to treat a subject having a disease caused by dengue virus. In one embodiment, the red yeast rice is prepared with the yeast Monascus purpureus.
Claims
exact text as granted — not AI-modified1 . A method of treating a subject having a disease caused by dengue virus, comprising the step of administering red yeast rice to the subject.
2 . The method of claim 1 , wherein the dengue virus is of serotype DEN-1, DEN-2, DEN-3, or DEN-4.
3 . The method of claim 1 , wherein the disease is dengue fever or dengue hemorrhagic fever.
4 . The method of claim 1 , wherein treatment with the red yeast rice results in increased thrombosis in the subject.
5 . The method of claim 1 , wherein the red yeast rice comprises a yeast in the genus of Monascus.
6 . The method of claim 5 , wherein the yeast is Monascus purpureus.
7 . The method of claim 1 , wherein the red yeast rice is formulated into capsule form.
8 . The method of claim 7 , wherein the treatment comprises taking three red yeast rice capsules per day for seven days.Join the waitlist — get patent alerts
Track US2013045227A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.